Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

<p class="Inside-first-paragraph-drop-cap">Vaccine advisors to the Food and Drug Administration face a tight timeline and a host of unknowns as they try to prepare for an expected winter surge of COVID-19, all the while acknowledging that any plan forward could be dashed by the emergence of a new variant of the pandemic virus. </p>

FDA Struggles to Find Way Forward on COVID-19 Vaccine

‘The best we can with the knowledge we have at hand’